US 10472357
Triazolopyridine compounds and methods for the treatment of cystic fibrosis
granted A61KA61K31/4196A61K31/437
Quick answer
US patent 10472357 (Triazolopyridine compounds and methods for the treatment of cystic fibrosis) held by Flatley Discovery Lab, LLC expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Flatley Discovery Lab, LLC
- Grant date
- Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/4196, A61K31/437, A61K31/4439, A61K31/444